Latest News
News
Blood test could predict future disability in MS
“This rising of NfL up to 2 years before signs of disability worsening represents the window when interventions may prevent worsening.”
Latest News
CKD-EPI eGFR formula surpasses alternatives in young adults
The 2021 race-free CKD-EPI equation for estimating glomerular filtration rate outperformed two alternative formulas in adults aged 18-40 years.
Conference Coverage
Survey: 42% of PCPs not familiar with biologics for asthma
“The results of the survey point to the need to improve the communication between primary care physicians and asthma care specialists, including...
Latest News
Actinic keratoses may predict skin cancers in older adults
AKs have been associated with a small risk for cutaneous SCC, but associations with risk for other skin cancers have not been well studied.
Latest News
Incipient ulceration may affect prognosis in primary melanoma
“Future editions of the AJCC staging system should consider acknowledging this interpretive challenge and provide guidance on how primary...
Conference Coverage
Blood pressure lowering reduces dementia risk
“This proven, effective intervention should be widely scaled up to reduce the global burden of dementia.”
News
FDA approves first tx for rare, deadly clotting disorder
First drug to treat TTP. a rare, lethal blood clotting disorder, has been greenlighted by the FDA.
Conference Coverage
Alpha-gal syndrome: Red meat is ‘just the beginning,’ expert says
“We are seeing increasing diagnoses of AGS in places that are not, perhaps, where we first thought this allergy existed.”
Conference Coverage
Obinutuzumab promotes renal preservation in lupus nephritis
A post hoc analysis of the NOBILITY trial showed improved outcomes for patients taking obinutuzumab (Gazyva), compared with placebo.
From the Journals
Salt intake associated with increased type 2 diabetes risk
“These findings provide support that reduction of adding salt to foods may act as a potential behavioral intervention approach for preventing T2D...
From the Journals
Short steroid taper tested with tocilizumab for giant cell arteritis
Results from a pilot study examining a shortened prednisone taper of 8 weeks’ length rather than 26 weeks suggest it may be possible to reduce...